The role of the fragile X mental retardation protein (FMRP) is well established in brain, where its absence leads to the fragile X syndrome (FXS). FMRP is almost ubiquitously expressed, suggesting that, in addition to its effects in brain, it may have fundamental roles in other organs. There is evidence that FMRP expression can be linked to cancer. FMR1 mRNA, encoding FMRP, is overexpressed in hepatocellular carcinoma cells. A decreased risk of cancer has been reported in patients with FXS while a patient-case with FXS showed an unusual decrease of tumour brain invasiveness. However, a role for FMRP in regulating cancer biology, if any, remains unknown. We show here that FMRP and FMR1 mRNA levels correlate with prognostic indicators of aggressive breast cancer, lung metastases probability and triple negative breast cancer (TNBC). We establish that FMRP overexpression in murine breast primary tumours enhances lung metastasis while its reduction has the opposite effect regulating cell spreading and invasion. FMRP binds mRNAs involved in epithelial mesenchymal transition (EMT) and invasion including E-cadherin and Vimentin mRNAs, hallmarks of EMT and cancer progression.
期刊论文详细信息
EMBO Molecular Medicine | |
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation | |
Rossella Lucá13  Michele Averna13  Francesca Zalfa1  Manuela Vecchi10  Fabrizio Bianchi3  Giorgio La Fata13  Franca Del Nonno14  Roberta Nardacci14  Marco Bianchi10  Paolo Nuciforo7  Sebastian Munck13  Paola Parrella4  Rute Moura13  Emanuela Signori6  Robert Alston12  Anna Kuchnio5,13  Maria Giulia Farace8,13  Vito Michele Fazio4  Mauro Piacentini14  Bart De Strooper13  Tilmann Achsel13  Giovanni Neri2,13  Patrick Neven11,13  D. Gareth Evans12  Peter Carmeliet5,13  Massimiliano Mazzone9,13  | |
[1] CIR Department, Faculty of Medicine, University “Campus Bio-Medico”, Rome, Italy;Institute of Medical Genetics, Catholic University, Rome, Italy;Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy;Laboratory of Oncology, IRCCS H. “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy;Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB, Leuven, Belgium;Institute of Translational Pharmacology, CNR, Rome, Italy;Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain;Department of Biomedicine and Prevention, University “Tor Vergata”, Rome, Italy;Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium;IFOM, Fondazione Istituto FIRC di Oncologia Moleculare, Milan, Italy;Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium;Cancer Research UK Paediatric and Familial Cancer Research Group, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK;VIB Center for the Biology of Disease, Leuven, Belgium;National Institute for Infectious Diseases, IRCCS ‘Lazzaro Spallanzani’, Rome, Italy | |
关键词: cell invasion; EMT; FMRP; mRNA metabolism; TNBC; | |
DOI : 10.1002/emmm.201302847 | |
来源: Wiley | |
【 摘 要 】
Abstract
【 授权许可】
CC BY
Copyright © 2013 EMBO Molecular Medicine
Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202107150009356ZK.pdf | 1594KB | download |